Comparision of two adjuvant opioid drugs fentanyl and nalbuphine used for spinal anaesthesia in lower limb surgeries
Phase 1
- Conditions
- Health Condition 1: M999- Biomechanical lesion, unspecified
- Registration Number
- CTRI/2021/05/033463
- Lead Sponsor
- Shri B M Patil Medical College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Adult patients aged between 18-60 years of both sex undergoing elective lower limb surgeries.
Patients belonging to ASA Grade Ð? and Ð?Ð?.
Exclusion Criteria
Infection at the site of injection.
Hypersensitivity to study drugs.
Coagulopathy or other bleeding diathesis.
Patients with peripheral neuropathy.
Patients with cardiac, pulmonary, hepatic or renal disorder.
Pregnancy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the onset and duration of sensory and motor blockade of fentanyl and nalbuphine adjuvant to bupivacaine.Timepoint: At 0, 5, 10, 15, 30, 60 and 120 minute and time of rescue analgesia.
- Secondary Outcome Measures
Name Time Method To compare the haemodynamic changes like heart rate and blood pressure, Time of rescue analgesia and Side effects of study drugs. <br/ ><br>Timepoint: At 0, 5, 10, 15, 30, 60 and 120 minute and time of rescue analgesia.